Back
T Rowe Price Ultra Short-Term Bond ETF Vs. Blueprint Medicines Industry Stock Comparison
Sell
12
TBUX
T Rowe Price Ultra Short-Term Bond ETF
Last Price:
$49.68
Seasonality Move:
-0.16%
Sell
40
BPMC
Blueprint Medicines
Last Price:
$102.47
Seasonality Move:
5.27%
Sell
12
T Rowe Price Ultra Short-Term Bond ETF (TBUX)
is a Sell
Is T Rowe Price Ultra Short-Term Bond ETF a Buy, Sell or Hold?
-
The current T Rowe Price Ultra Short-Term Bond ETF [TBUX] share price is $49.68. The Score for TBUX is 12, which is 76% below its historic median score of 50, and infers higher risk than normal.
-
TBUX is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
40
Blueprint Medicines (BPMC)
is a Sell
Is Blueprint Medicines a Buy, Sell or Hold?
-
The current Blueprint Medicines [BPMC] share price is $102.56. The Score for BPMC is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
-
BPMC is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
TBUX Stock Price Chart
What is T Rowe Price Ultra Short-Term Bond ETF's stock price today?
-
The T Rowe Price Ultra Short-Term Bond ETF share price today is $49.68The current trend is relatively stagnant and TBUX is experiencing selling pressure, which indicates risk of future bearish movement.
BPMC Stock Price Chart
What is Blueprint Medicines's stock price today?
-
The Blueprint Medicines share price today is $102.56Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BPMC is experiencing selling pressure, which indicates risk of future bearish movement.
TBUX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.03 | Sell |
Relative Strength Index (14 RSI): | 49.9 | Sell |
Chaikin Money Flow: | -67401 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | ( - ) | Buy |
Bollinger Bands (100): | ( - ) | Buy |
BPMC Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.85 | Buy |
Relative Strength Index (14 RSI): | 63.82 | Buy |
Chaikin Money Flow: | -913925 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (88.06 - 96.6) | Buy |
Bollinger Bands (100): | (86.99 - 95.95) | Buy |
TBUX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 49.64 | Buy |
20-day SMA: | 49.69 | Sell |
50-day SMA: | 49.72 | Sell |
200-day SMA: | 49.63 | Buy |
8-day EMA: | 49.66 | Buy |
20-day EMA: | 49.68 | Buy |
50-day EMA: | 49.71 | Sell |
200-day EMA: | 49.61 | Buy |
BPMC Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 92.93 | Buy |
20-day SMA: | 91.76 | Buy |
50-day SMA: | 93.83 | Buy |
200-day SMA: | 96.87 | Buy |
8-day EMA: | 94.89 | Buy |
20-day EMA: | 92.92 | Buy |
50-day EMA: | 92.72 | Buy |
200-day EMA: | 91.71 | Buy |
T Rowe Price Ultra Short-Term Bond ETF Earnings Growth & TBUX Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Blueprint Medicines Earnings Growth & BPMC Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.71 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.41 per share, and an increase next year of $2.89 per share.
T Rowe Price Ultra Short-Term Bond ETF Technical Analysis
Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | Jan 7 | Jan 8 | Jan 10 | Jan 13 | Jan 14 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
30 | 31 | 02 | 03 | 06 | 07 | 08 | 10 | 13 | 14 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Blueprint Medicines Technical Analysis
Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | Jan 7 | Jan 8 | Jan 10 | Jan 13 | Jan 14 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
30 | 31 | 02 | 03 | 06 | 07 | 08 | 10 | 13 | 14 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |